Efficacy and Safety Study of Diclofenac HPBCD 25, 50 mg/ml Administered as Single s.c. Dose, in the Treatment of Acute Moderate-to-severe Post-surgical Pain From Dental Surgery (Impacted 3rd Molar Extraction).

Trial Profile

Efficacy and Safety Study of Diclofenac HPBCD 25, 50 mg/ml Administered as Single s.c. Dose, in the Treatment of Acute Moderate-to-severe Post-surgical Pain From Dental Surgery (Impacted 3rd Molar Extraction).

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Apr 2013

At a glance

  • Drugs Diclofenac (Primary)
  • Indications Dental pain; Postoperative pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Feb 2011 Additional lead trial investigator (Dietrich T) added as reported by ClinicalTrials.gov.
    • 18 Feb 2010 Actual patient number (333) added as reported by ClinicalTrials.gov.
    • 18 Feb 2010 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top